NLRP3 and cancer: Although the effect of Sch B on IL-1β has seldomly been observed in cancer models, its inhibitory effect on nuclear factor kappa-light-chain-enhancer of activated B cells (NF-ĸB), the central mediator of the priming signal of NLRP3 inflammasome, has been investigated in lung cancer cell lines [26].